Skip to main content
. 2015 Apr 30;5:9905. doi: 10.1038/srep09905

Figure 3. (a) Cumulative meta-analysis of the XRCC1-Arg399Gln polymorphism and prostate cancer.

Figure 3

(b) Cumulative meta-analysis of theXRCC1-Arg280His polymorphism and prostate cancer risk.